Dillon Eustace recently advised BGF Investment Management, an investor in growth companies, on its equity investment in Vasorum Ltd. Dillon Eustace acted on behalf of limited partnerships BGF Ireland 1A and BGF Investments, both managed by BGF Investment Management. This investment is part of BGF’s €250 million fund dedicated to growth funding in Ireland.
The investment represents a major equity investment for Vasorum Ltd and a strategic addition to BGF’s portfolio. Vasorum Ltd, founded in 2007, is a Dublin based high-growth medical device business specialising in sophisticated devices used to close arterial punctures in vascular, cardiology and radiology procedures. The company operating from Dublin has more than 70,000 patient implants to date in both the EU and USA.
The Dillon Eustace legal team on this transaction was led by Lorcan Tiernan, Partner and Head of Corporate M&A, and supported by Owen Brayden.
